Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Melanoma 1

Interventions

Radiotherapy 2 Lenalidomide 2 Carboplatin 2 tislelizumab 1 irinotecan sucrosofate 1 enzalutamide 1 Ruthenium-106 1 Radiotherapy, Intensity-Modulated 1 Paclitaxel 1 Melphalan 1 Mannitol 1 Leukocyte Count 1 Folfox protocol 1 Dexamethasone 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Enrolling by invitation × Ruthenium-106 × Clear all

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡